Doping Journal Noteworthy Articles

Noteworthy section of the Doping Journal (ISSN 1812-948x) alerts interested readers about the selected noteworthy original research and viewpoint/review articles, book reviews, and meeting reports (published in other journals) on the subject of the Doping Journal scope.

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates  | Contact us
We work for athletes, not corrupted antidoping officials, donate now to help us

March 25, 2007

Famprofazone as the source of methamphetamine and amphetamine in urine specimen collected during sport competition

J Forensic Sci. 2007 Mar;52(2):479-86
Tseng YL, Lin CT, Wang SM, Liu RH.
Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan
PubMed ID & Record:
17316255

During a sport competition event in Taiwan, one urine specimen was found positive for both methamphetamine (2688 ng/mL) and amphetamine (462 ng/mL). The specimen donor claimed that she had taken Gewolen (a nonprescription drug manufactured in Taiwan) for treating abdominal pain and the medication was presented. Laboratory investigation confirmed that Gewolen contains famprofazone, which is known to metabolize to methamphetamine and amphetamine and is included in the prohibited list of the World Anti-Doping Agency. Study on the excretion profiles of three volunteers ingesting 50 mg famprofazone produced the following patterns similar to that observed in the case specimen: (a) the ratio of methamphetamine to amphetamine was approximately 6 to 1; (b) d- and l-enantiomers of both methamphetamine and amphetamine were present, while the amount of l-methamphetamine was 3-4-fold greater than its counterpart. The data suggested that famprofazone (as the ingredient of Gewolen) was likely the source of the prohibited drugs found in the case specimen.

0 Comments:

Post a Comment

<< Home

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates | Contact us